Skip to content

Education Interventions Model for Rational Drug Use (RDU)

Education Interventions Model for Rational Drug Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01281215
Enrollment
120
Registered
2011-01-21
Start date
2011-03-31
Completion date
2012-10-31
Last updated
2018-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Pharmaceutical Education, Rational Drug Use, Asthma

Brief summary

The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.

Detailed description

Currently, the educational interventions regarding the use of medicines need to be expanded and more effective, and thus set themselves up in strategies for reorganization of dispensing drugs in health services and provide support to the population to obtain greater control over their health. The pharmacist, in turn, inserted in the multidisciplinary team has an important role in health education with the aim of improving knowledge about the disease and the various treatment options, reflecting positively on treatment adherence and clinical outcomes as a result and quality of life related to patient health. Thus, health education, to share knowledge, represents an important task and involves attentive listening to the community to identify their needs and then solve them. From this perspective, therefore, the educational means to educate health and an integral formation of individuals as social actors critics who understand and question the social relations, transforming subjects into citizens participating in the process of health education, helping to raise awareness , knowledge and understanding of living conditions and relationships with health, promoting quality of life.

Interventions

BEHAVIORALEducation interventional

The patients will receive pharmaceutical education to know more about asthma, the importance of treatment compliance, the medications used to control the pathology, corrected patients' inhalation techniques and the medication care.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject with asthma diagnosed according to criteria of the Global Strategy for Asthma Management and Prevention; * Subject is a male or female with 18 to 73 years-old; * Subject who has access to medications supplied by the the Brazil Heath Care System; * Subject unable to perform the procedures or conditions such as pregnancy that may affect the results of the study; * Literate subject without Cognitive Disorders, Alzheimer's, Dementia, that can limit the ability to participate in this study; * Subject who have availability to attend the monthly meetings; * Subject provides written informed consent and attend the first evaluation.

Exclusion criteria

* Subject who cannot be classified in the inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Knowledge of Asthma6 months after the first evaluationTo compare the patient´s knowledge of asthma before and after the education interventions with asthma knowledge questionnaire.

Secondary

MeasureTime frameDescription
Sociodemographic data, clinical and lifestyle evaluation6 months after the first evaluationTo evaluate the sociodemographic data, clinical and lifestyle before and after the education interventions and its impact on the quality of life.
Management of inhalers6 months after the first evaluationTo evaluate the technique for using inhalation devices among asthma patients before and after education interventions. Patients will be asked to demonstrate their inhaler technique.
Spirometry Exam6 months after the first evaluationTo compare the patient´s pulmonary function before and after the education interventions with spirometry exam.
Economic analysis6 months after the first evaluationEconomic analysis after the model implementation.
Quality of Life Evaluation6 months after the first evaluationTo compare the Quality of Life before and after the education interventions
Treatment compliance evaluation6 months after the first evaluationTo evaluate the treatment compliance with Morisky&Green test and pharmacy database query before and after educations interventions.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026